These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 8877248)
41. Impact of shorter-acting neuromuscular blocking agents on fast-track recovery of the cardiac surgical patient. Murphy GS; Szokol JW; Marymont JH; Avram MJ; Vender JS; Rosengart TK Anesthesiology; 2002 Mar; 96(3):600-6. PubMed ID: 11873034 [TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics of rocuronium bromide in paediatric patients. O'Kelly B; Fiset P; Meistelman C; Ecoffey C Eur J Anaesthesiol Suppl; 1994; 9():57-8. PubMed ID: 7925210 [TBL] [Abstract][Full Text] [Related]
43. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia. Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538 [TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis. Khalil M; D'Honneur G; Duvaldestin P; Slavov V; De Hys C; Gomeni R Anesthesiology; 1994 Jun; 80(6):1241-7. PubMed ID: 8010470 [TBL] [Abstract][Full Text] [Related]
45. Precurarization and priming: a theoretical analysis of safety and timing. Kopman AF; Khan NA; Neuman GG Anesth Analg; 2001 Nov; 93(5):1253-6. PubMed ID: 11682407 [TBL] [Abstract][Full Text] [Related]
46. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure. Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242 [TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics and pharmacodynamics of rocuronium bromide in adult patients. Alvarez-Gomez JA; Estelles ME; Fabregat J; Perez F; Brugger AJ Eur J Anaesthesiol Suppl; 1994; 9():53-6. PubMed ID: 7925209 [TBL] [Abstract][Full Text] [Related]
48. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124 [TBL] [Abstract][Full Text] [Related]
49. Safety and efficacy of rocuronium for controlled intubation with paralytics in the pediatric emergency department. Mendez DR; Goto CS; Abramo TJ; Wiebe RA Pediatr Emerg Care; 2001 Aug; 17(4):233-6. PubMed ID: 11493818 [TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics of rocuronium during the three stages of liver transplantation. Fisher DM; Ramsay MA; Hein HA; Marcel RJ; Sharma M; Ramsay KJ; Miller RD Anesthesiology; 1997 Jun; 86(6):1306-16. PubMed ID: 9197300 [TBL] [Abstract][Full Text] [Related]
51. Sedation after intubation using etomidate and a long-acting neuromuscular blocker. Kendrick DB; Monroe KW; Bernard DW; Tofil NM Pediatr Emerg Care; 2009 Jun; 25(6):393-6. PubMed ID: 19458564 [TBL] [Abstract][Full Text] [Related]
52. Cardiac effects of non-depolarizing neuromuscular blocking agents pancuronium,vecuronium, and rocuronium in isolated rat atria. Melnikov AL; Malakhov KY; Helgesen KG; Lathrop DA Gen Pharmacol; 1999 Oct; 33(4):313-7. PubMed ID: 10523069 [TBL] [Abstract][Full Text] [Related]
53. [How to titrate rocuronium under specific conditions]. Ozaki M Masui; 2008 Jul; 57(7):831-7. PubMed ID: 18649637 [TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics of rocuronium bromide in patients with and without renal failure. Cooper RA; Mirakhur RK; Wierda JM; Maddineni VR Eur J Anaesthesiol Suppl; 1995 Sep; 11():43-4. PubMed ID: 8557005 [TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. Szenohradszky J; Fisher DM; Segredo V; Caldwell JE; Bragg P; Sharma ML; Gruenke LD; Miller RD Anesthesiology; 1992 Nov; 77(5):899-904. PubMed ID: 1443743 [TBL] [Abstract][Full Text] [Related]
57. The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat. Khuenl-Brady K; Castagnoli KP; Canfell PC; Caldwell JE; Agoston S; Miller RD Anesthesiology; 1990 Apr; 72(4):669-74. PubMed ID: 1969717 [TBL] [Abstract][Full Text] [Related]
58. Effects of priming with pancuronium or rocuronium on intubation with rocuronium in children. Lee SK; Kim JR; Bai SJ; Shin YS; Nam YT; Cohen SP Yonsei Med J; 1999 Aug; 40(4):327-30. PubMed ID: 10487134 [TBL] [Abstract][Full Text] [Related]
59. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers. Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568 [TBL] [Abstract][Full Text] [Related]
60. Dose-response and time-course of action of rocuronium bromide. Mirakhur RK Eur J Anaesthesiol Suppl; 1995 Sep; 11():23-5. PubMed ID: 8557001 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]